Pesquisar | ValuTok

Komal Galande adicionou um novo artigo Literature
2026-04-06 08:04:45

Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?
Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
KUMUD SINGH adicionou um novo artigo Health
2026-03-24 11:53:50

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Komal Galande adicionou um novo artigo Crafts
2026-03-16 06:07:42

Will Endocrine Resistance-Targeting Drugs Transform the Future of Cancer Therapy?
Market Trends Shaping Executive Summary Endocrine Resistance–Targeting Drug Market Market Size and Share CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...

0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!